Campbell Rebecca K, Gray Emma, Caskey Rachel, Barkowski Cristina, Wallander Gemkow Jena, Mohanty Nivedita, Rankin Kristin, Haider Sadia
School of Public Health, University of Illinois Chicago, Chicago, Illinois, USA.
College of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.
J Womens Health (Larchmt). 2025 May;34(5):704-714. doi: 10.1089/jwh.2024.0691. Epub 2025 Feb 7.
Postpartum care, including contraception, benefits maternal health and decreases mortality, which increased in the United States with COVID-19. Pandemic disruptions to postpartum health care access in vulnerable populations are not well understood. We utilize electronic health record (EHR) data for prenatal patients ( = 2,265) at six urban Federally Qualified Health Centers (FQHCs) from one year prepandemic (January 1, 2019) through one year after the first stay-at-home orders ("lockdown") (March 31, 2021). We investigated (1) changes in rates of postpartum visit (PPV) and postpartum contraception receipt in the post-lockdown versus prepandemic periods and (2) characteristics predictive of differential changes in PPV and contraception rates. Visit and prescription records from EHR were used to classify if patients received PPV and most/moderately effective contraception within 60 days postpartum, analyzed separately and as a composite variable: PPV and contraception, PPV only, or no PPV. Risk differences comparing post-lockdown with pre-COVID-19 pandemic were estimated using binomial regression and generalized logistic regression models adjusted for age, race/ethnicity, language, and clinical site. Effect modification by sociodemographic and clinical covariates was examined. Total patient volume fell 21% in the post-lockdown versus pre-COVID-19 period. Rates of PPV decreased in absolute terms by 9.6 (95% confidence interval: -13.6, -5.6) and contraception by 8.1 (-13.3, -2.8) percentage points. After adjustment, PPV and contraception decreased by 9.3 percentage points (-13.1, -5.4), while PPV only was stable (-0.4 [-4.3, 3.6]). These findings suggest a substantial impact of the COVID-19 pandemic on postpartum care in FQHCs and community health centers. Supply and demand drivers require further examination to inform strategies to improve postpartum care access and subsequent maternal health outcomes.
产后护理,包括避孕,对孕产妇健康有益并可降低死亡率,而在美国,随着新冠疫情的出现,孕产妇死亡率有所上升。疫情对弱势群体产后医疗保健服务的影响尚未得到充分了解。我们利用了六家城市联邦合格健康中心(FQHCs)产前患者(n = 2265)的电子健康记录(EHR)数据,时间跨度从疫情前一年(2019年1月1日)到首次居家令(“封锁”)后一年(2021年3月31日)。我们调查了:(1)封锁后与疫情前产后就诊(PPV)率和产后避孕接受率的变化;(2)预测PPV和避孕率差异变化的特征。EHR中的就诊和处方记录用于分类患者在产后60天内是否接受了PPV以及最/中度有效的避孕措施,分别分析并作为一个复合变量:PPV和避孕、仅PPV或无PPV。使用二项式回归和广义逻辑回归模型估计封锁后与新冠疫情前的风险差异,并对年龄、种族/族裔、语言和临床地点进行了调整。研究了社会人口统计学和临床协变量的效应修正。与新冠疫情前相比,封锁后患者总数下降了21%。PPV率绝对值下降了9.6个百分点(95%置信区间:-13.6,-5.6),避孕率下降了8.1个百分点(-13.3,-2.8)。调整后,PPV和避孕率下降了9.3个百分点(-13.1,-5.4),而仅PPV则保持稳定(-0.4 [-4.3,3.6])。这些发现表明,新冠疫情对FQHCs和社区健康中心的产后护理产生了重大影响。供需驱动因素需要进一步研究,以制定改善产后护理服务可及性及后续孕产妇健康结局的策略。